Sharechat Logo

Cannasouth Limited (NZX: CBD) Raises $4.5m in New Capital

Tuesday 3rd August 2021

Text too small?

Cannasouth Limited is pleased to announce that its recently closed Share Purchase Plan and retail offer (Offer) has raised a total of $4,500,000 through the issue of 11,250,000 new ordinary fully paid shares and 3,750,000 options.

In terms of the Offer, for every three shares subscribed for, an investor received one option. The options have a 2-year expiry date and an exercise price $0.40 per share. They will not be quoted on the NZX Main Board. Investors will be sent a direct communication in due course providing further information as to the manner in which an option may be exercised.

On 5 July 2021, Cannasouth announced that it was seeking to raise up to $6 million to consolidate its operations by acquiring outstanding interests it does not already own, in each of Midwest Pharmaceutics NZ Limited and Cannasouth Cultivation Limited, and to provide additional growth capital.

Given the Company has raised $4.5 million to date, the Company will now seek to place the balance of $1.5 million prior to 30 September 2021.

Cannasouth expects that the new shares will be allotted, and holder statements sent out to shareholders, on or about Friday 6 August 2021.

Please see the link below for details

NZX MAP_CBD_Capital Raise Results

Source: Cannasouth Limited

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

EROAD Limited (NZX: ERD) launches Clarity Solo Dashcam
22nd October 2021 Morning Report
Pictor ready to roll out game-changing COVID antibody test in New Zealand
Scott Technology Limited (NZX: SCT) Announces FY21 Results
21st October 2021 Morning Report
Greenfern Industries Limited (NZX: GFI) L&Q Notice
TruScreen Group Limited (NZX: TRU) Clinical Trial Results Highlight Efficacy of TRU Technology
20th October 2021 Morning Report
Freightways Limited (NZX: FRE) Acquisition of ProducePronto
19th October 2021 Morning Report